Bellicum Pharmaceuticals (FRA:BPXA) Other Gross PPE : €0.01 Mil (As of Sep. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Bellicum Pharmaceuticals Other Gross PPE?

Bellicum Pharmaceuticals's Other Gross PPE for the quarter that ended in Sep. 2023 was €0.01 Mil.

Bellicum Pharmaceuticals's quarterly Other Gross PPE declined from Mar. 2023 (€0.02 Mil) to Jun. 2023 (€0.02 Mil) and declined from Jun. 2023 (€0.02 Mil) to Sep. 2023 (€0.01 Mil).

Bellicum Pharmaceuticals's annual Other Gross PPE declined from Dec. 2020 (€0.69 Mil) to Dec. 2021 (€0.59 Mil) and declined from Dec. 2021 (€0.59 Mil) to Dec. 2022 (€0.00 Mil).

Bellicum Pharmaceuticals Other Gross PPE Historical Data

The historical data trend for Bellicum Pharmaceuticals's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bellicum Pharmaceuticals Other Gross PPE Chart

Bellicum Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Gross PPE

Get a 7-Day Free Trial

28.30

9.06

0.69

0.59

Bellicum Pharmaceuticals Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Gross PPE	Get a 7-Day Free Trial															0.02	-	0.02	0.02	0.01

Bellicum Pharmaceuticals Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Bellicum Pharmaceuticals (FRA:BPXA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bellicum Pharmaceuticals Inc (FRA:BPXA) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

BLCM:USA

Address

3730 Kirby Drive, Suite 1200, Houston, TX, USA, 77098

Website

https://www.bellicum.com

Bellicum Pharmaceuticals Inc is a biopharmaceutical company that has discovered and developed novel, controllable cellular immunotherapies for various forms of cancer, including both hematological cancers and solid tumors. its proprietary Chemical Induction of Dimerization technology platform is designed to enable control of components of the immune system in real-time. Its product candidates are; BPX-601 an autologous GoCAR-T product candidate designed to treat solid tumors expressing prostate stem cell antigen, or PSCA, and BPX-603 an autologous dual-switch GoCAR-T product candidate designed to target solid tumors that express the human epidermal growth factor receptor 2 antigen, or HER2.

Bellicum Pharmaceuticals (FRA:BPXA) Headlines

No Headlines